Abstract:Bone cancer pain is one of the most severe and intractable complications in patients suffering from primary or metastatic bone cancer and profoundly compromises the quality of life. Emerging evidence indicates that the dorsal root ganglion play an integral role in the modulation of pain hypersensitivity. However, the underlying molecular mechanisms during dorsal root ganglion-mediated bone cancer pain remain elusive. In this study, RNA-sequencing was used to detect the differentially expressed genes in dorsal root ganglion neurons of a rat bone cancer pain model established by intratibial inoculation of Walker 256 breast cancer cells. Gene ontology and Kyoto Encyclopedia of Genes and Genomes analysis showed that the differentially expressed genes (fold change > 1.5; false discovery rate < 0.05) were enriched in the bone morphogenetic protein (BMP) signaling pathway, transforming growth factor-beta signaling pathway, and positive regulation of cartilage development. Importantly, serum deprivation-response protein (Sdpr), hephaestin (Heph), transthyretin (Ttr), insulin receptor substrate 1 (Irs1), connective tissue growth factor (Ctgf ), and Bmp2 genes were associated with bone pain and degeneration. Of note, Bmp2, a pleiotropic and secreted molecule mediating pain and inflammation, was one of the most significantly upregulated genes in dorsal root ganglion neurons in this bone cancer pain model. Consistent with these data, upregulation of Bmp2 in the bone cancer pain model was validated by immunohistochemistry, real-time quantitative polymerase chain reaction, and western blotting. Importantly, intrathecal administration of siRNA significantly reduced Bmp2 transcription and ameliorated bone cancer pain in rat as shown by paw withdrawal mechanical threshold and spontaneous and movement-evoked pain-like behaviors. In conclusion, we have characterized the comprehensive gene expression profile of dorsal root ganglion from a bone cancer pain rat model by RNA-sequencing and identified Bmp2 as a potential therapeutic target for bone cancer pain treatment.

Role Of Tlr4/Nf-Kappa B Signal Transduction Pathway In The Formation Of Bone Cancer Pain In Rats

Role of TLR 4 / NF-κ B signal transduction pathway in the formation of bone cancer pain in rats

Down-Regulation of Toll-Like Receptor 4 Gene Expression by Short Interfering RNA Attenuates Bone Cancer Pain in a Rat Model

[The Role of Brain-Derived Neurotrophic Factor in Pain Facilitation and Spinal Mechanism in Rat Model of Bone Cancer Pain].

Stage-dependent Anti-Allodynic Effects of Intrathecal Toll-like Receptor 4 Antagonists in a Rat Model of Cancer Induced Bone Pain

Participation of spinal CaMKII-NR2B signal pathway in the development of bone cancer pain in mice

[Express] Roles of TNF-α and IL-6 in regulating bone cancer pain via TRPA1 signal pathway and beneficial effects of inhibition of neuro-inflammation and TRPA1.

Roles of tumor necrosis factor-α and interleukin-6 in regulating bone cancer pain via TRPA1 signal pathway and beneficial effects of inhibition of neuro-inflammation and TRPA1

Nuclear Factor Kappa B Regulated Monocyte Chemoattractant Protein-1/Chemokine CC Motif Receptor-2 Expressing in Spinal Cord Contributes to the Maintenance of Cancer-Induced Bone Pain in Rats.

Involvement of EphB1 receptor/ephrinB1 ligand in bone cancer pain.

Role of spinal cord TNF-α in the development of bone cancer pain in mice

Role of IL-1β and TNFα in the Spinal Cord in a Murine Model of Bone Cancer Pain Reduced by Activation of Glial Cells

Inducible Lentivirus-Mediated Sirna Against TLR4 Reduces Nociception in a Rat Model of Bone Cancer Pain

Role of Tumor Necrosis Factor-Α in Spinal Cord in the Development of Mouse Bone Cancer Pain

Upregulation of bone morphogenetic protein 2 ( Bmp2) in dorsal root ganglion in a rat model of bone cancer pain.

Activation of the BMP2-SMAD1-CGRP Pathway in Dorsal Root Ganglia Contributes to Bone Cancer Pain in a Rat Model

Netrin-1 Role in Nociceptive Neuron Sprouting through Activation of DCC Signaling in a Rat Model of Bone Cancer Pain

Activation of the Camp-Pka Signaling Pathway in Rat Dorsal Root Ganglion and Spinal Cord Contributes Toward Induction and Maintenance of Bone Cancer Pain.

A rat model of bone cancer pain induced by intra-tibia inoculation of Walker 256 mammary gland carcinoma cells.

Brain‐derived Neurotrophic Factor Modulates N‐methyl‐D‐aspartate Receptor Activation in a Rat Model of Cancer‐induced Bone Pain

Pain Behavior and the Expression of Phosphorylated Camp Response Element Binding Protein and Brain-Derived Neurotrophic Factor in Dorsal Horn of Spinal Cord in a Mouse Model of Bone Cancer Pain